your market intelligence analyst
Search Results
177 results
Your search is now limited to «Inflammation» expert search.
Business Wire 02/19/2020 07:30
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Announces Positive Topline Results from Phase 3 TRuE-AD Program evaluating Ruxolitinib Cream in Patients with Atopic Dermatitis.
More from Business Wire:
FeedNavigator (EU) 02/18/2020 11:23
Background: Several natural products have been reported to elicit beneficial effects against neurodegenerative disorders due to their vitamin E contents. However, the neuroprotective efficacy of palm oil or its tocotrienol-rich fraction (TRF) from the pre-clinical cell and animal studies have not been systematically reviewed. Methods: The protocol for this systematic review was registered in “PROSPERO” (CRD42019150408). This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. The Medical Subject Heading (MeSH) descriptors of PubMed with Boolean operators were used to construct keywords, including (“Palm Oil”[Mesh]) AND “Nervous System”[Mesh], (“Palm Oil”[Mesh]) AND “Neurodegenerative D.
More from FeedNavigator (EU):
Seeking Alpha 02/17/2020 11:17
TTP399 can prove to be a promising treatment option in T1D indication. There are high chances of azeliragon proving effective in treating dementia in diabetes p.
More from Seeking Alpha: 02/14/2020 06:38
The term astrogliosis may sound unfamiliar to the general public, but this inflammatory process is common to several diseases such as Parkinson's, Alzheimer's, multiple sclerosis and congenital malformations caused by the Zika virus.
More from 02/13/2020 13:58
Inflammation, which causes the redness and itchiness typical of AD, can be triggered by internal or external elements, such as a bacterial infection.
More from
Updated Date: Wed, 12 Feb 2020 00:00:00 EST.
More from National Library of Medicine - DailyMed Drug Label Updates (NLM):
LocalTechWire 02/11/2020 07:34
T3D Therapeutics, a 7-year-old company started with loan help from the North Carolina Biotechnology Center, said today it is launching a Phase 2 clinical trial with its unique product candidate, T3D-959, to treat mild to moderate forms of Alzheimer’s disease (AD).
More from LocalTechWire: 02/10/2020 08:49
Conditions : Alzheimer Disease; Mild Cognitive Impairment Intervention : Drug: Tacrolimus Sponsor : Massachusetts General Hospital Not yet recruiting.
More from
Global Research 02/10/2020 01:59
Environmentalist Dr Rosemary Mason has just written the report ‘’. It has been sent to editors of major media outlets in …. .
More from Global Research:
Synapse loss and mitochondrial stress, as seen by separate PET tracers, go hand-in-hand in Alzheimer’s, Parkinson’s, and frontotemporal dementia.
More from Alzheimer's Research & Therapy:
(MENAFN - Online PR News) Healthy Energy Amazing Life, LLC has received 2 awards: Retailer and Consumer Choice : Best New Product: H.E.A.L. OSIMAGNESI...
More from Middle East North Africa Financial Network (MENAFN):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications